EWM
VXRT

Empirical Wealth Management’s Vaxart VXRT Stock Holding History

Empirical Wealth Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,385
Closed -$9.37K – 515
2023
Q1 		$9.37K Buy
+12,385
New +$11.5K ﹤0.01% 461

Other funds holding VXRT

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Empirical Wealth Management's VXRT Position: Q2 2023 in Review

Empirical Wealth Management sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 12,385 shares — an estimated $9.37K sold.

Empirical Wealth Management first reported a position in VXRT in Q1 2023 and held it in 1 quarter. The position peaked at $9.37K in Q1 2023. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Empirical Wealth Management reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Empirical Wealth Management sold 12,385 Vaxart shares in Q2 2023, an estimated $9.37K.
  • Empirical Wealth Management first reported a position in Vaxart in Q1 2023 and held it in 1 quarter.
  • Empirical Wealth Management's Vaxart position peaked at $9.37K in Q1 2023.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Empirical Wealth Management's 13F filing for Q2 2023, filed 11 Aug 2023.